TEVA
Teva Pharmaceutical Industries LtdCompany with tickers: TEVA, TEVJF
CIK
818686
CUSIP
881624209
Shares Outstanding
1,164,426,972
13F Activity (30d)
528 filings
502 filers
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | $3,982,000,000 | USD | 2026-03-31 | 10-Q | 2026-04-29 |
| Cost of Revenue | — | ||||
| Gross Profit | $1,972,000,000 | USD | 2026-03-31 | 10-Q | 2026-04-29 |
| Operating Expenses | — | ||||
| Research & Development | — | ||||
| Operating Income | $652,000,000 | USD | 2026-03-31 | 10-Q | 2026-04-29 |
| Net Income | $369,000,000 | USD | 2026-03-31 | 10-Q | 2026-04-29 |
| EPS (Basic) | $0.32 | USD/shares | 2026-03-31 | 10-Q | 2026-04-29 |
| EPS (Diluted) | $0.31 | USD/shares | 2026-03-31 | 10-Q | 2026-04-29 |